Jenburkt Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - FormulationsNSE
₹893.20
-7.10-0.79% (1D)
As on 20 Nov 2026 at 15:53
As of 20 Nov 2026 at 15:53, Jenburkt Pharmaceuticals Ltd is trading at ₹893.20. The 52-week range stands at ₹845.00–₹1,260.00, with a market cap of ₹396.91 crore. At a P/E of 11.09 and a dividend yield of 2.30%, it is a small-cap stock in the Pharmaceuticals sector.

JENBURPH Price Chart

Market Cap
₹396.91 Cr
PE Ratio
11.09
ROCE
20.75%

Jenburkt Pharmaceuticals Ltd Performance

Jenburkt Pharmaceuticals Ltd Fundamentals

Know More
Market Cap₹396.91 Cr
ROE16.04%
P/E Ratio (TTM)11.09
EPS (TTM)₹81.07
P/B Ratio1.94
Dividend Yield2.30%
Industry P/E91.72
Book Value₹464.35
Debt to Equity0.01
Face Value₹10

Jenburkt Pharmaceuticals Ltd Shareholding Pattern

Know More
Promoter46.6%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0%
Public53.4%

Jenburkt Pharmaceuticals Ltd Financial Statements

Know More
No data for this view.

Jenburkt Pharmaceuticals Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals Limited was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family during the period 1986. The Company engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. It works more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation serve to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23. Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year. FY 2026 saw genuine distinction while the Company launched Cartisafe Forte, India's first fixed-dose combination of Undenatured Type II Collagen (40 mg), Glucosamine HCl (1500 mg), Chondroitin Sulphate (50 mg), and Hyaluronic Acid (30 mg). It launched Nervijen DP - a Pregabalin + Duloxetine combination available in Monthly Compliance Packs (50 mg and 75 mg variants) . Further, it launched Powergesic Natura Oil in association with KLE Ayurvedic Medical College, Belagavi. Additionally, Company launched Powergesic Gel 15 gm, Zixspas, Zixlam Forte, and Piritexyl LD during the year.

Parent Organisation—
Founded1985
Managing DirectorAshish U Bhuta
NSE SymbolJENBURPH

Jenburkt Pharmaceuticals Ltd Resistance and Support levels

R3946.67R2932.57R1923.86S1895.67S2886.96S3872.87893.20

Jenburkt Pharmaceuticals Ltd Technicals

Current Price
₹893.20 ₹7.10 (-0.79%)
Bearish
12
Bullish
0
  • 20 Day3.7%
  • 50 Day6.1%
  • 100 Day7.0%
  • 200 Day7.0%

Jenburkt Pharmaceuticals Ltd Latest News

View More
No recent news available.

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Annual ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Jenburkt Pharmaceuticals Ltd is ₹893.20 as of 20 Nov 2026 at 15:53.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now